retatrutide news today october 2025 The Thriving Black Market for a Powerful Weight Loss Drug How Does Retatrutide Make You

It is frequently compared with Tirzepatide (a dual GIP/GLP-1 agonist) and Retatrutide (a triple agonist) in research settings exploring GLP-1 agonist efficacy differences

No, it is not safe

it triggers glucose-dependent insulin release from the pancreas (meaning insulin goes up when blood sugar is high, not when it is already normal)

[1] While there is no official link established between GLP-1 therapy and magnesium deficiency, the gastrointestinal side effects may theoretically increase the risk of suboptimal magnesium intake or absorption

Request your consultation today

"I still find myself thinking, has that actually happened?" Tirzepatide is one of a group of weight-loss drugs known as GLP-1 receptor agonists, which work by making the patient feel fuller for longer